Volunteers experiencing a vaccine against coronavirus in Sechenovskiy University, feel good, reaction to the vaccine did not last more than a day, said Last news the head of the Center clinical study of medicine First Moscow state medical University Elena Smolyarchuk.
Clinical vaccine testing from COVID-19 was launched in Sechenovskiy University on June 18.
As explained Smolyarchuk, the first group of volunteers the Vaccine was introduced already more than 3 weeks ago, the second group a little more than 2 weeks ago.
Minor post-vaccination reaction, manifested in volunteers did not differ from reactions to other vaccines - redness at the injection site, someone has a headache, someone has a fever, sore throat, joint pain, said the scientist. The severity of these reactions was minimal, for this reason, intervention of physicians was not necessary, all the reactions were stopped throughout the day.
Excerpt volunteers at good health it is expected fifteen and 20 July, she said.
According Smolyarchuk, this Vaccine is subject to productivity and security has the ability to be applied not only in Russia but also abroad. The vaccine created by a biotechnological process, for this reason can not cause the disease by vaccination, because human organism do not enter the virus itself neither in the living nor in inaktivirovannoj condition, said the expert.
now also in parallel tested the Vaccine, created SIC name Gamalei, testing this vaccine along with this center by the Ministry of defense, which has already reported on the good health of the volunteers after 2 weeks of testing. In addition, the General Director of "Vector" Rinat Maksyutov reported Last news that the 3 sample of vaccine for coronavirus infection was developed in the centre, have successfully passed the checks.
Current information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.